Global Consensus Position Statement on the Use of Testosterone Therapy for Women.
暂无分享,去创建一个
I. Lambrinoudaki | S. Davis | L. Vignozzi | N. Panay | J. Simon | J. Rymer | J. Bitzer | R. Baber | S. Kingsberg | M. Wierman | A. Kaunitz | S. Parish | R. Islam | J. Pinkerton | S. C. Perez | James H. Liu
[1] M. Page,et al. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. , 2019, The lancet. Diabetes & endocrinology.
[2] I. Goldstein,et al. Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part III. , 2019, The journal of sexual medicine.
[3] P. Chedraui,et al. Sexual well-being after menopause: An International Menopause Society White Paper , 2018, Climacteric : the journal of the International Menopause Society.
[4] I. Goldstein,et al. The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women , 2018, Mayo Clinic proceedings.
[5] A. Morice,et al. Developing Clinical Guidelines. , 2017, American journal of respiratory and critical care medicine.
[6] L. Schover,et al. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. , 2017, The journal of sexual medicine.
[7] Frederick C W Wu,et al. A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications. , 2017, Endocrine reviews.
[8] N. Panay,et al. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. , 2017, Fertility and sterility.
[9] L. Derogatis,et al. Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part I. , 2016, The journal of sexual medicine.
[10] B. Komisaruk,et al. Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part II. , 2016, The journal of sexual medicine.
[11] V. Montori,et al. Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. , 2014, The Journal of clinical endocrinology and metabolism.
[12] A. Heijboer,et al. Accuracy of first and second generation testosterone assays and improvement through sample extraction. , 2012, Clinical chemistry.
[13] G. Brabant,et al. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry. , 2012, The Journal of clinical endocrinology and metabolism.
[14] H. Vesper,et al. Toward excellence in testosterone testing: a consensus statement. , 2010, The Journal of clinical endocrinology and metabolism.
[15] S. Ratcliffe,et al. Determinants of serum total and free testosterone levels in women over the age of 65 years. , 2007, The Journal of clinical endocrinology and metabolism.
[16] S. Davis,et al. MALE AND FEMALE SEXUAL FUNCTION AND DYSFUNCTION; ANDROLOGY Circulating Androgen Levels and Self-Reported Sexual Function in Women , 2006 .
[17] S. Davis,et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. , 2005, The Journal of clinical endocrinology and metabolism.
[18] Christina Wang,et al. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. , 2004, The Journal of clinical endocrinology and metabolism.